FHTXVSGTBP• 3 Months (Normalized)
FHTX vs GTBP (Foghorn Therapeutics Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Jul 7 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
FHTX Performance $2
-66.67%
Foghorn Therapeutics Inc.
Normalized Baseline0.00%
GTBP Performance $6.16
+1239.13%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-1305.8 pts
GTBP outperforming by 1305.80 percentage points
FHTXGTBP
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
FHTX GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | FHTX Price | FHTX Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $2.00 | -66.67% | $6.16 | +1239.13% | -1305.80% |
| Oct 02, 2026 | $2.02 | -66.33% | $6.10 | +1226.09% | -1292.42% |
| Sep 29, 2026 | $- | $6.88 | +1394.57% | - | |
| Sep 28, 2026 | $- | $6.80 | +1378.26% | - | |
| Sep 25, 2026 | $3.54 | -41.00% | $6.89 | +1397.83% | -1438.83% |
| Sep 24, 2026 | $3.60 | -40.00% | $6.83 | +1384.78% | -1424.78% |
| Sep 23, 2026 | $3.87 | -35.50% | $7.10 | +1443.48% | -1478.98% |
| Sep 22, 2026 | $4.24 | -29.33% | $- | - | |
| Sep 21, 2026 | $4.15 | -30.83% | $7.18 | +1460.87% | -1491.70% |
| Sep 18, 2026 | $4.14 | -31.00% | $7.16 | +1456.52% | -1487.52% |
| Sep 17, 2026 | $4.20 | -30.00% | $7.49 | +1528.26% | -1558.26% |
| Sep 16, 2026 | $4.17 | -30.50% | $7.81 | +1597.83% | -1628.33% |
| Sep 15, 2026 | $4.12 | -31.33% | $9.00 | +1856.52% | -1887.85% |
| Sep 14, 2026 | $4.36 | -27.33% | $11.63 | +2428.26% | -2455.59% |
| Sep 11, 2026 | $4.42 | -26.33% | $8.61 | +1771.74% | -1798.07% |
Page 1 of 5